The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO
Official Title: ARCHER 1042: A PHASE 2 STUDY OF DACOMITINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (POST-CHEMOTHERAPY OR SELECT FIRST LINE PATIENTS) TO EVALUATE PROPHYLACTIC INTERVENTION ON DERMATOLOGIC AND GASTROINTESTINAL ADVERSE EVENTS AND PATIENT REPORTED OUTCOMES
Study ID: NCT01465802
Brief Summary: To assess the impact of prophylactic treatment on the incidence of adverse events in advanced NSCLC patients (post chemotherapy) treated with dacomitinib daily as a single agent. To assess the impact of an interrupted dacomitinib dosing schedule in Cycle 1 on the incidence of adverse events in first-line advanced NSCLC patients with an EGFR mutation (HER-1 mutation, HER-2 mutation or HER-2 amplification).
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
City of Hope, Duarte, California, United States
St. Jude Heritage Healthcare, Fullerton, California, United States
UCLA Hematology Oncology, Irvine, California, United States
UC San Diego Medical Center - La Jolla, La Jolla, California, United States
UC San Diego Moores Cancer Center - Investigational Drug Services, La Jolla, California, United States
UC San Diego Moores Cancer Center, La Jolla, California, United States
Drug Management Only: UCLA West Medical Pharmacy, Los Angeles, California, United States
Drug Management Only: UCLA West Medical Pharmacy Attn: Steven L. Wong, Pharm.D., Los Angeles, California, United States
Drug Management Only: UCLA West Medical Pharmacy, Los Angeles, California, United States
Drug Managment Only: UCLA West Medical Pharmacy, Los Angeles, California, United States
Regulatory Management Only TRIO-US Central Administration, Los Angeles, California, United States
Regulatory Management Only: TRIO-US Central Administration, Los Angeles, California, United States
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
UCLA Hematology Oncology, Los Angeles, California, United States
Westwood Bowyer Clinic, Los Angeles, California, United States
UCLA/Pasadena HealthCare, Pasadena, California, United States
UC San Diego Medical Center - Hillcrest, San Diego, California, United States
Coastal Integrative Cancer Care, San Luis Obispo, California, United States
SANSUM Clinic, Santa Barbara, California, United States
Cancer Center of Santa Barbara with SANSUM Clinic, Santa Barbara, California, United States
Central Coast Medical Oncology Corporation, Santa Maria, California, United States
UCLA Hematology Oncology, Santa Monica, California, United States
UCLA Santa Monica Medical Center & Orthopaedic Hospital, Santa Monica, California, United States
Cancer Center of Santa Barbara with SANSUM Clinic, Solvang, California, United States
City of Hope South Pasadena Cancer Center, South Pasadena, California, United States
UCLA/Santa Clarita Valley Cancer Center, Valencia, California, United States
UCLA Cancer Center, Westlake Village, California, United States
Kaiser Permanente Colorado - Franklin, Denver, Colorado, United States
St. Mary's Hospital Regional Cancer Center, Grand Junction, Colorado, United States
Kaiser Permanente Colorado - Rock Creek, Lafayette, Colorado, United States
Kaiser Permanente Colorado - Lonetree, Lonetree, Colorado, United States
Michael and Dianne Bienes Comprehensive Cancer Center, Holy Cross Hospital, Fort Lauderdale, Florida, United States
Memorial Cancer Institute, Hollywood, Florida, United States
Cancer Care of North Florida, PA, Lake City, Florida, United States
Memorial West Cancer Institute, Pembroke Pines, Florida, United States
University Cancer & Blood Center, LLC, Athens, Georgia, United States
Summit Cancer Care,PC, Savannah, Georgia, United States
Summit Cancer Care, PC, Savannah, Georgia, United States
Rush University Medical Center, Division of Hematology & Oncology, Chicago, Illinois, United States
Ships Drugs to: Emmanuel Semmes, RPh (or Ami Patel, Pharm D) University of Chicago, Chicago, Illinois, United States
University of Chicago Medical Center, Chicago, Illinois, United States
Illinois CancerCare, P.C., Peoria, Illinois, United States
Cancer Center of Kansas, Wichita, Kansas, United States
Cancer Center of Kansas, Wichita, Kansas, United States
Josephine Ford Cancer Center-Downriver, Brownstown, Michigan, United States
Henry Ford Medical Center - Fairlane, Dearborn, Michigan, United States
Henry Ford Hospital, Detroit, Michigan, United States
Henry Ford Medical Center - Columbus, Novi, Michigan, United States
Henry Ford Hospital and Medical Center - West Bloomfield, West Bloomfield, Michigan, United States
The West Clinic, PC, Corinth, Mississippi, United States
The West Clinic, PC, Southaven, Mississippi, United States
Mercy Clinic Cancer & Hematology-Branson, Branson, Missouri, United States
Mercy Hospital Springfield, Springfield, Missouri, United States
Mercy Clinic Cancer and Hematology - Chub O-Reilly Cancer Center, Springfield, Missouri, United States
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
Saint Barnabas Medical Center, Livingston, New Jersey, United States
Montefiore-Einstein Center for Cancer Care, Bronx, New York, United States
Montefiore Medical Center, Bronx, New York, United States
Beth Israel Medical Center, New York, New York, United States
Beth Israel Comprehensive Cancer Center, New York, New York, United States
Columbia University Medical Center - The New York Presbyterian Hospital, New York, New York, United States
Stony Brook University Medical Center-Cancer Center, Stony Brook, New York, United States
Carolina Oncology Specialists, PA, Hickory, North Carolina, United States
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Legacy Pharma Research, Bismarck, North Dakota, United States
Mid Dakota Clinic, PC, Bismarck, North Dakota, United States
St Alexius Medical Center, Bismarck, North Dakota, United States
Charleston Hematology Oncology Associates, PA, Charleston, South Carolina, United States
The West Clinic, PC, Memphis, Tennessee, United States
The West Clinic, PC, Memphis, Tennessee, United States
Investigational Product Center (IPC), Fort Worth, Texas, United States
Investigational Products Center (IPC), Fort Worth, Texas, United States
'Fletcher Allen Health Care, Inc, Burlington, Vermont, United States
Office of Clinical Trials Research, Fletcher Allen Health Care, Inc., Burlington, Vermont, United States
Virginia Cancer Specialists, PC, Fairfax, Virginia, United States
Swedish Cancer Institute - Issaquah, Issaquah, Washington, United States
Swedish Cancer Institute, Seattle, Washington, United States
Swedish Medical Center, Seattle, Washington, United States
Seoul National University Hospital, Seoul, , Korea, Republic of
Severance Hospital, Yonsei University Health System, Seoul, , Korea, Republic of
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR